Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132.
Saved in:
| Title: | Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. |
|---|---|
| Authors: | Burge DJ; Resolve Therapeutics, Miami, Florida, USA., Werth VP; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Boackle SA; University of Colorado School of Medicine, Aurora, Colorado, USA., Posada J; Resolve Therapeutics, Miami, Florida, USA jp@resolvebio.com. |
| Source: | Lupus science & medicine [Lupus Sci Med] 2024 Feb 07; Vol. 11 (1). Date of Electronic Publication: 2024 Feb 07. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38325898 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burge+DJ%22">Burge DJ</searchLink>; Resolve Therapeutics, Miami, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Werth+VP%22">Werth VP</searchLink>; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Boackle+SA%22">Boackle SA</searchLink>; University of Colorado School of Medicine, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Posada+J%22">Posada J</searchLink>; Resolve Therapeutics, Miami, Florida, USA jp@resolvebio.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101633705%22">Lupus science & medicine</searchLink> [Lupus Sci Med] 2024 Feb 07; Vol. 11 (1). <i>Date of Electronic Publication: </i>2024 Feb 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101633705 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2053-8790 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220538790%22">20538790 </searchLink><i>NLM ISO Abbreviation: </i>Lupus Sci Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38325898 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/lupus-2023-001113 Languages: – Code: eng Text: English Titles: – TitleFull: Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burge DJ – PersonEntity: Name: NameFull: Werth VP – PersonEntity: Name: NameFull: Boackle SA – PersonEntity: Name: NameFull: Posada J IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 02 Text: 2024 Feb 07 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2053-8790 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Lupus science & medicine Type: main |
| ResultId | 1 |
